Skip to main content
logo
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
8.87
-0.38 (-4.11%)
At close: Sep 4, 2026, 4:00 PM EDT
8.93
+0.06 (0.68%)
After-hours: Sep 4, 2026, 4:47 PM EDT

Aspire Biopharma Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.10.01---
Revenue Growth
-----
Gross Profit
-0.02-0---
Operating Income
7.04-5.22-1.21-0.36-0.6
Net Income
-11.05-24.48-1.31-0.36-0.6
Earnings Per Share
-33.33-491.27-56.96-0.00-
EPS Growth
-----

Revenue by Geography
Chart
Fiscal YearFY 2025
Period EndingDec '25
United States
0.01
Canada
0
United Kingdom
0
Total
0.01

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
12.17100.010
Total Debt
-5.181.270.360.03
Net Cash (Debt)
12.17-4.17-1.26-0.35-0.03
Net Cash Growth
-----
Net Cash Per Share
36.71-83.71-54.93-0.00-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-7.19-4.92-0.270.01-0.14
Free Cash Flow
-7.19-4.92-0.270.01-0.14
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-25.04%-1.87%---
Operating Margin
7210.15%-84167.06%---
Pretax Margin
-11314.12%-394725.06%---
Profit Margin
-11314.13%-394725.06%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
132.852285.75---